Skip to content

BioPoly® Great Toe Hemiarthroplasty Implant 135-5118Recalls & reported problems

Biopoly, LLC · BioPoly® Great Toe Hemiarthroplasty Implant - 18mm Porous · Class 2 · Implant

Data updated Oct 18, 2026 from official FDA records · Editorial policy

Adverse event reports
3
Deaths reported
0
Injuries reported
1
Recalls naming it
0

Summary

The FDA's MAUDE database contains 3 adverse event reports that list this exact device (DI 00850012119401), received between Jun 26, 2023 and May 22, 2024 — classified as 1 injury, 2 malfunctions.

The most frequently reported specific device problem is “Off-Label Use” (2 reports).

Reports come from manufacturers, hospitals and patients and are not verified by the FDA. A report does not prove the device caused the event, and counts can't be used to compare devices or estimate failure rates. What reports can and can't tell you · How this data works · Data updated Oct 18, 2026.

Reports received per month

Nov 2023: 0 reportsDec 2023: 0 reportsJan 2024: 0 reportsFeb 2024: 0 reportsMar 2024: 0 reportsApr 2024: 0 reportsMay 2024: 1 reportsJun 2024: 0 reportsJul 2024: 0 reportsAug 2024: 0 reportsSep 2024: 0 reportsOct 2024: 0 reportsNov 2024: 0 reportsDec 2024: 0 reportsJan 2025: 0 reportsFeb 2025: 0 reportsMar 2025: 0 reportsApr 2025: 0 reportsMay 2025: 0 reportsJun 2025: 0 reportsJul 2025: 0 reportsAug 2025: 0 reportsSep 2025: 0 reportsOct 2025: 0 reportsNov 2025: 0 reportsDec 2025: 0 reportsJan 2026: 0 reportsFeb 2026: 0 reportsMar 2026: 0 reportsApr 2026: 0 reportsMay 2026: 0 reportsJun 2026: 0 reportsJul 2026: 0 reportsAug 2026: 0 reportsSep 2026: 0 reportsOct 2026: 0 reports2024202520261
Last 36 months. The most recent month may be incomplete.

Most reported problems

Device problems

  • Off-Label Use2
  • Insufficient Device Problem Information1
  • Use of Device Problem1

Patient problems

  • Implant Pain1
  • Inadequate Osseointegration1
  • Insufficient Information1
  • Osteolysis1
  • Pain1

Recent adverse event reports

The 3 most recent of 3 reports, in the reporter's own words as published by the FDA.

  • MalfunctionMay 22, 2024Off-Label Use; Off-Label Use

    BIOPOLY LEARNED FROM A PHYSICIAN ABOUT A REVISION SURGERY TO REMOVE A BIOPOLY GREAT TOE IMPLANT AFTER THE PATIENT PRESENTED WITH PAIN.

    Patient problems: Inadequate Osseointegration

    MAUDE report 19369957 ↗
  • MalfunctionJul 11, 2023Off-Label Use; Use of Device Problem; Off-Label Use; Use of Device Problem

    BIOPOLY LEARNED FROM PHYSICIAN ABOUT OSTEOLYSIS/BONE RESORPTION IN ONE OF HIS PATIENTS, AND HE REMOVED THE BIOPOLY IMPLANT.

    Patient problems: Osteolysis

    MAUDE report 17299738 ↗
  • InjuryJun 26, 2023Insufficient Device Problem Information; Insufficient Device Problem Information

    A PATIENT DEVELOPED JOINT STIFFNESS AND PAIN AND HAD THE BIOPOLY IMPLANT REMOVED.

    Patient problems: Implant Pain; Insufficient Information; Pain

    MAUDE report 17200186 ↗

Other Prosthesis, Toe, Hemi-, Phalangeal devices

All Prosthesis, Toe, Hemi-, Phalangeal devices →

Sources and updates

How reports and recalls are matched · Editorial policy · Report an error on this page